Back Bay Life Science Advisors

Back Bay Life Science Advisors offers integrated strategy consulting and investment banking execution for the life sciences. We guide biotech, pharmaceutical, and medical technology companies and their investors on development, commercialization, growth, and maintenance of market share. Back Bay provides clear and unbiased advice and execution for the critical decisions that drive value. In 2023, Back Bay entered a strategic partnership with DNB Bank to provide healthcare companies with strategic guidance, M&A and partnering support and execution and capabilities in global capital markets and investment and commercial banking. Together, as an international collaboration, DNB and Back Bay Life Science Advisors...

Strategy consulting,financial advisory,biotech,medical device ,pharmaceutical ,m&a,cross-border transaction ,divestitures,licensing/partnerships,franchise ,valuation ,clinical ,scientific ,qualitative and quantitative analytics,early-stage r&d strategy,life cycle management ,product positioning ,corporate growth strategy,exit planning ,market assessment and forecasting,client merger ,client acquisition,and investment banking

Back bay life science advisors operates in the Strategic management services industry.

Back bay life science advisors's revenue is 1m - 10m

Back bay life science advisors has 11 - 50 employees.